The evaluation of efficacy and safety of methotrexate and pioglitazone in psoriasis patients: A randomized, open-labeled, active-controlled clinical trial
CONCLUSIONS: Pioglitazone alone or in combination with standard treatment may be a safe alternative drug for psoriasis coexisting with MS proving beneficial for both.
Source: Indian Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Afroz Abidi Dilshad Ali Rizvi Kshitij Saxena Savita Chaudhary Ali Ahmad Source Type: research
More News: Actos | Clinical Trials | Drugs & Pharmacology | Epidemiology | India Health | Metabolic Syndrome | Methotrexate | Psoriasis | Study